Literature DB >> 8863172

Should the 3C (craniocerebellocardiac) syndrome be included in the spectrum of velocardiofacial syndrome and DiGeorge sequence?

M G Butler, P Mowrey.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8863172      PMCID： PMC1050717          DOI： 10.1136/jmg.33.8.719-a

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  7 in total

1.  3C syndrome: another case.

Authors:  L C Mims; B Say
Journal:  Clin Genet       Date:  1989-12       Impact factor: 4.438

Review 2.  Atrioventricular canal and 3C (cranio-cerebello-cardiac) syndrome.

Authors:  M C Digilio; B Marino; A Giannotti; R Mingarelli; B Dallapiccola
Journal:  Am J Med Genet       Date:  1995-07-31

3.  An additional patient with the 3C syndrome.

Authors:  F Gurrieri; G Neri
Journal:  Clin Genet       Date:  1992-05       Impact factor: 4.438

4.  3C (cranio-cerebello-cardiac) syndrome: a recently delineated and easily recognizable congenital malformation syndrome.

Authors:  J J Hoo; M Kreiter; N Halverson; A Perszyk
Journal:  Am J Med Genet       Date:  1994-08-01

5.  Dandy-Walker(like) malformation, atrio-ventricular septal defect and a similar pattern of minor anomalies in 2 sisters: a new syndrome?

Authors:  D Ritscher; A Schinzel; E Boltshauser; J Briner; U Arbenz; P Sigg
Journal:  Am J Med Genet       Date:  1987-02

6.  Cerebellar atrophy in a patient with velocardiofacial syndrome.

Authors:  D R Lynch; D M McDonald-McGinn; E H Zackai; B S Emanuel; D A Driscoll; L A Whitaker; K H Fischbeck
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

Review 7.  3C syndrome: third occurrence of cranio-cerebello-cardiac dysplasia (Ritscher-Schinzel syndrome).

Authors:  A Verloes; M F Dresse; M Jovanovic; P Dodinval; F Geubelle
Journal:  Clin Genet       Date:  1989-03       Impact factor: 4.438
  7 in total
  1 in total

1.  Absence of a del(22q11) in a patient with the 3C (craniocerebellocardiac) syndrome.

Authors:  J M Saraiva; E Matoso; I Marques
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.